By Unknown Rabu, 08 Juli 2015 boards of directors conflicts of interest executive compensation mission-hostile management Mylan perverse incentives Who Benefits? - Rising Generic Drug Prices and the Case of Mylan's Conflicted Property Purchases Rising Generic Drug Prices Health care costs in the US continue their seemingly inexorable rise. Even the parts of health care that used to...